FDA Drug recall D-0641-2024
Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg, 100-count bottles, Distributed by: Aurohealth…
- FDA Drug
- Class I
- ongoing
- Published 2024-08-28
On 2024-08-28 the FDA classified a Class I recall of Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg, 100-count bottles, Distributed by: Aurohealth… by Aurobindo Pharma Usa, citing labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0641-2024 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2024-07-11 |
| Published | 2024-08-28 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Aurobindo Pharma Usa |
| Distribution | NJ, NY, PA |
Product
Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg, 100-count bottles, Distributed by: Aurohealth LLC, 279 Princeton-Hightstown Road, East Windsor, NJ , Made in India, NDC 58602-882-21.
Reason
Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.
Identifiers
| ndc | 58602-882-21 |
|---|---|
| ndc | 58602-882-38 |
| code_info | Lot#: AC2523005A, Exp 6/30/2025 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0641-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.